The Crosstalk Between YAP/TAZ and Cancer Metabolism: From Mechanistic Insights to Drug Discovery
The interplay between YAP/TAZ and metabolic reprogramming in cancer is systematically clarified, the core molecular networks through which YAP/TAZ govern each metabolic pathway are delineated, and the current pharmacological inhibitors targeting YAP/TAZ-regulated metabolic networks are summarized.